|
|
||||||||




*
Department of Human Genetics, Mount Sinai School of Medicine, New York, NY 10029; Departments of
Gastroenterology, Hepatology, and Infectious Diseases and
Pediatric Hematology and Oncology, and
Institute of Immunology, Otto-von-Guericke University, Magdeburg, Germany; and
¶ Medical Faculty, Institute of Physiological Chemistry, Martin Luther University Halle-Wittenberg, Wittenberg, Germany
Human cathepsin W (also called lymphopain) is a recently described
papain-like cysteine protease of unknown function whose gene expression
was found to be restricted to cytotoxic cells. Here we demonstrate that
cathepsin W is expressed predominantly in NK cells and, to a lesser
extent, in CTLs. Quantitative RT-PCR revealed that NK cells contained
21 times more cathepsin W transcript than CTLs. The predominant
expression of cathepsin W in NK cells was further confirmed by Western
blot analysis and immunohistochemistry. IL-2-mediated stimulation of NK
cells and CTLs revealed a stronger up-regulation of the cathepsin W
gene and protein expression in NK cells (7-fold) than in CTLs (2-fold).
Transfection experiments of HeLa cells and biochemical analyses
revealed that cathepsin W is exclusively "high mannose-type"
glycosylated and is mainly targeted to the endoplasmic reticulum (ER).
Interestingly, the ER localization of cathepsin W was also found in NK
cells, in which colocalization studies revealed an overlapping staining
of cathepsin W and Con A, an ER-specific lectin. Furthermore,
subcellular fractionation of cathepsin W-expressing cells confirmed the
ER localization and showed that cathepsin W is membrane associated.
Based on the results of this study, cathepsin W might represent a
putative component of the ER-resident proteolytic machinery. The
constitutive expression in NK cells and the stronger up-regulation of
cathepsin W by IL-2 in NK cells than CTLs suggest that cathepsin W is
not just a marker of cytotoxic cells but is, rather, specifically
expressed in NK cells.
This article has been cited by other articles:
![]() |
G. Birkus, N. Kutty, G.-X. He, A. Mulato, W. Lee, M. McDermott, and T. Cihlar Mol. Pharmacol., July 1, 2008; 74(1): 92 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giraud, P.-J. Lejeune, J. Barbaria, and B. Mallet A Plasminogen-Like Protease in Thyroid Rough Microsomes Degrades Thyroperoxidase and Thyroglobulin Endocrinology, June 1, 2007; 148(6): 2886 - 2893. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Monsurro, E. Wang, Y. Yamano, S. A. Migueles, M. C. Panelli, K. Smith, D. Nagorsen, M. Connors, S. Jacobson, and F. M. Marincola Quiescent phenotype of tumor-specific CD8+ T cells following immunization Blood, October 1, 2004; 104(7): 1970 - 1978. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Ondr and C. T. N. Pham Characterization of Murine Cathepsin W and Its Role in Cell-mediated Cytotoxicity J. Biol. Chem., June 25, 2004; 279(26): 27525 - 27533. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Buhling, N. Waldburg, A. Reisenauer, A. Heimburg, H. Golpon, and T. Welte Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation Eur. Respir. J., April 1, 2004; 23(4): 620 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dozmorov, M. R. Saban, N. P. Gerard, B. Lu, N.-B. Nguyen, M. Centola, and R. Saban Neurokinin 1 receptors and neprilysin modulation of mouse bladder gene regulation Physiol Genomics, February 6, 2003; 12(3): 239 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Balaji, N. Schaschke, W. Machleidt, M. Catalfamo, and P. A. Henkart Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation J. Exp. Med., August 19, 2002; 196(4): 493 - 503. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |